About Pelvalon
Pelvalon is a Healthcare company based in Sunnyvale (United States) founded in 2010, and was acquired by Laborie Medical in October 2021. Vaginal insert for bowel control. The company was acqui-hired. Pelvalon offers products and services including Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is Laborie Medical Technologies Corp. Its competitors include Axonics, Averto Medical and Boomerang Medical; 3 of its 3 listed competitors have raised funding.
Company details
Eclipse is the a vaginal insert designed to provide bowel control in women with fecal incontinence. The insert is placed in the same location as a tampon or a diaphragm, and can be removed at any time. A detachable and discreet pump is used to inflate and deflate a balloon on the insert. The balloon is designed to control the rectum and prevent stool from passing when the patient is not ready for it. When the patient is ready to have a bowel movement, they may simply deflate the balloon to pass stool.
- Headquarters Sunnyvale, United States
- Stage Acquired
- SectorsHealthcare
- Website pelvalon.com
- Social LinkedIn X Facebook YouTube
- Acquired by Laborie Medical (Oct 2021)
- Legal Name Laborie Medical Technologies Corp.
- InvestorsLaborie Medical
& 1 more
- Acquired byLaborie Medical
(Oct 2021)
Products & Services of Pelvalon
Pelvalon offers a comprehensive portfolio of products and services, including Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule.
Treats fecal incontinence through non-surgical vaginal insert.
Assists in evaluating urinary tract function in clinical settings.
Manages benign prostatic hyperplasia with drug-coated balloon.
Monitors reflux in gastroenterology patients effectively.
Apps and channels of Pelvalon
its YouTube channel Laborie Medical Technologies Corp has 4.9K subscribers and 2 videos.
Videos from Pelvalon
The most watched videos on Pelvalon's YouTube channel, Laborie Medical Technologies Corp (4.9K subscribers). Click a video to play it here.
More on Laborie Medical Technologies Corp.
Funding Insights of Pelvalon
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Pelvalon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2009 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Pelvalon
Pelvalon has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Laborie Medical and Stanford Biodesign.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Project-based bio-design courses are offered to Stanford graduates and post-docs. | biodesign.stanford.edu | Stanford, United States | ||
Medical products for female lower urinary tract dysfunctions are provided. | 1967 | laborie.com | Mississauga, Canada |
Investor details for Pelvalon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pelvalon
3 dated milestones of Pelvalon across 12 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round.
- Founded Pelvalon is founded.
- Exit Acquired by Laborie Medical.
Competitors of Pelvalon
Pelvalon has 3 listed competitors in our database, 3 of them funded. They include Axonics, Averto Medical and Boomerang Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| axonics.com | 2013 | Irvine, United States | $143.47M | 762 | Sacral neuromodulation devices are developed for urinary and bowel control. | |
| avertomed.com | 2016 | Fremont, United States | $33M | 18 | Medical devices for gastrointestinal disease patients are developed. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | Bioelectronic devices are developed for autoimmune disease treatment. |
Detailed competitors of Pelvalon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pelvalon
Websites that share an audience with Pelvalon (pelvalon.com).
Websites whose visitors overlap most with Pelvalon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Gastroenterology
3 companies that operate in the same segment as Pelvalon (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pelvalon
Pelvalon was founded in 2010.
Pelvalon is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Eclipse is the a vaginal insert designed to provide bowel control in women with fecal incontinence. The insert is placed in the same location as a tampon or a diaphragm, and can be removed at any time. A detachable and discreet pump is used to inflate and deflate a balloon on the insert. The balloon is designed to control the rectum and prevent stool from passing when the patient is not ready for it. When the patient is ready to have a bowel movement, they may simply deflate the balloon to pass stool.
Pelvalon's top competitors include Axonics, Averto Medical and Boomerang Medical.
Pelvalon offers Eclipse System, NXT Family of Urodynamics Systems, Optilume BPH Catheter System, and alpHaONE Wireless pH Capsule.
Pelvalon has 2 investors. Key investors include Laborie Medical, and Stanford Biodesign.
Pelvalon operates through Laborie Medical Technologies Corp..
Yes. Pelvalon was acquired by Laborie Medical in October 2021.